Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay W Pettegrew

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
Acetyl-l-carnitine as a possible therapy for Alzheimer's diseaseJay W Pettegrew, Richard J McClure
Cell Biochemistry and Biophysics|August 23, 2008
Clinically relevant concentration determination of inhaled anesthetics (halothane, isoflurane, sevoflurane, and desflurane) by 19F NMRPravat K Mandal, Jay W Pettegrew
Biochimica Et Biophysica Acta|July 22, 2008
Abeta peptide interactions with isoflurane, propofol, thiopental and combined thiopental with halothane: a NMR studyPravat K Mandal, Jay W Pettegrew
Neurochemical Research|March 9, 2004
Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environmentPravat K Mandal, Jay W Pettegrew
Neurochemical Research|January 28, 2005
Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studiesPravat K Mandal, Jay W Pettegrew
Neurochemical Research|January 28, 2005
Interactions of Abeta(1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studiesPravat K Mandal, Richard J McClure, Jay W Pettegrew
Neurochemical Research|June 30, 2006
Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studiesPravat K Mandal, Jay W Pettegrew, Dennish W McKeag, et al.
Neurochemical Research|September 2, 2006
Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body diseasePravat K Mandal, Jay W Pettegrew, Eliezer Masliah, et al.
Schizophrenia Research|February 27, 2004
Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophreniaVaibhav A Diwadkar, Michael D DeBellis, John A Sweeney, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|April 25, 2006
Premorbid characterization in schizophrenia: the Pittsburgh High Risk StudyMatcheri S Keshavan, Vaibhav A Diwadkar, Debra M Montrose, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|October 9, 2009
Acetyl-l-carnitine as a possible therapy for Alzheimer's diseaseJay W Pettegrew, Richard J McClure
Cell Biochemistry and Biophysics|August 23, 2008
Clinically relevant concentration determination of inhaled anesthetics (halothane, isoflurane, sevoflurane, and desflurane) by 19F NMRPravat K Mandal, Jay W Pettegrew
Biochimica Et Biophysica Acta|July 22, 2008
Abeta peptide interactions with isoflurane, propofol, thiopental and combined thiopental with halothane: a NMR studyPravat K Mandal, Jay W Pettegrew
Neurochemical Research|March 9, 2004
Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environmentPravat K Mandal, Jay W Pettegrew
Neurochemical Research|January 28, 2005
Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studiesPravat K Mandal, Jay W Pettegrew
Neurochemical Research|January 28, 2005
Interactions of Abeta(1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studiesPravat K Mandal, Richard J McClure, Jay W Pettegrew
Neurochemical Research|June 30, 2006
Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studiesPravat K Mandal, Jay W Pettegrew, Dennish W McKeag, et al.
Neurochemical Research|September 2, 2006
Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body diseasePravat K Mandal, Jay W Pettegrew, Eliezer Masliah, et al.
Schizophrenia Research|February 27, 2004
Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophreniaVaibhav A Diwadkar, Michael D DeBellis, John A Sweeney, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|April 25, 2006
Premorbid characterization in schizophrenia: the Pittsburgh High Risk StudyMatcheri S Keshavan, Vaibhav A Diwadkar, Debra M Montrose, et al.
Pageof 3